Analyst
Fed
Equibles does not estimate personal net worth.
Brian Scorney is recorded as Analyst at Fed. Brian Scorney has spoken on 1 earnings call across 1 company, most recently for Crinetics Pharmaceuticals, Inc. on May 8, 2025. The companies whose calls Brian Scorney spoke on are classified in the Healthcare sector.
“Just also on the CAH study, in terms of enrollment criteria, how do you kind of compare exclusion and inclusion criteria to the catalyst study? Are there differences in criteria around GC dose A4, 17 OHP to consider?”
Fed
Analyst
Transcript header (unverified)
Crinetics Pharmaceuticals, Inc.
Biotechnology · Healthcare
Crinetics Pharmaceuticals, Inc. Q1 FY2025 Earnings Call
Crinetics Pharmaceuticals, Inc.
